Skip to main content
Clinical Trials/IRCT20191231045967N1
IRCT20191231045967N1CompletedPhase 3

Survey the effect of vitamin D3 tablet intake, positivism group consulting with changing in life style in the treatment of premenstrual syndrome in women

Yazd University of Medical Sciences0 sites84 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
84

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 40 years (—)
Sex
Female

Inclusion Criteria

  • Being a resident of Rafsanjan city
  • No history of treatment or depression or anxiety disorder
  • No history of treatment or eating disorder
  • No history of treatment or anemia disorder
  • No history of treatment or thyroid disorder
  • No history of treatment or presence of diabetes
  • Not taking birth control pills for medical reasons
  • Not taking any herbal medicine or medicine that affects premenstrual syndrome
  • Lack of treatment with psychiatric drugs and other non-pharmacological methods
  • Lack of treatment with other non-medicinal methods
  • Having two consecutive menstrual cycles a year with symptoms of premenstrual syndrome with at least five symptoms, one of which are mood disorders, which begin in the second half of the menstrual cycle and improve after menstruation, according to the self-report.
  • Having at least a 30% increase in symptom severity within 5 days before menstruation based on the PMS
  • Willingness to continue collaborating on tasks for 6 weeks
  • Failure to participate in another related study until the expiration of the current study

Exclusion Criteria

  • Severe form of premenstrual syndrome with a score of 35 and more from the premenstrual syndrome calendar

Investigators

Sponsor
Yazd University of Medical Sciences

Similar Trials